[EN] NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION<br/>[FR] NOUVEAUX INHIBITEURS DE LA REPLICATION DU VIRUS DE L'HEPATITE C
                        
                            
                                申请人:INTERMUNE INC
                            
                            
                                公开号:WO2011057215A1
                            
                            
                                公开(公告)日:2011-05-12
                            
                            The embodiments provide compounds of the general Formula 1, in which the substituents are as in the description, and compound 105S, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition. Formula (I)